Search Login Register

lenalidomide (CC 5013) Summary

Description: an immunomodulator

Also Known As: CC 5013; Revlimid; 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; CC-5013 Show All >>

Networked: 1416 relevant articles (261 outcomes, 326 trials/studies) for this Drug

Key Diseases for which lenalidomide is Relevant

  1. Multiple Myeloma : 123 outcomes 149 studies in 718 results
  2. Myelodysplastic Syndromes (Myelodysplastic Syndrome) : 31 outcomes 28 studies in 192 results
  3. Neoplasms (Cancer) : 15 outcomes 40 studies in 182 results
  4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 10 outcomes 9 studies in 35 results
  5. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) : 8 outcomes 12 studies in 64 results
Show All >>

Drugs Related to lenalidomide

  1. Thalidomide (Thalomid)
  2. bortezomib (Velcade)
  3. Dexamethasone (Maxidex)
  4. Proteasome Endopeptidase Complex (Proteasome)
  5. lenalidomide (CC 5013)
  6. pomalidomide
  7. Prednisone (Sone)
  8. rituximab (Mabthera)
  9. Cyclophosphamide (Cytoxan)
  10. carfilzomib
Show All >>

Therapies Related to lenalidomide

  1. Stem Cell Transplantation
  2. Drug Therapy (Chemotherapy)
  3. Aftercare (After-Treatment)
  4. Salvage Therapy
  5. Immunotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.